Skip to main content

Table 1 Socio-demographic and clinical characteristics of HAART experienced children at the UoGCSH, 2020

From: Seroprevalence of hepatitis B and C virus among highly active antiretroviral therapy experienced children in Gondar, Ethiopia

Variables

Category

N (%)

Sex

Male

121 (50.2)

Female

120 (49.8)

Age

2–10

59 (24.5)

11–15

182 (75.5)

Residence

Urban

215 (89.2)

Rural

26 (10.8)

Education

No

20 (8.3)

Primary

191 (79.3)

Secondary

30(12.4)

Marital status of family

Married

129 (53.5)

Separate/single

30 (12.4)

Widowed

82 (34)

Family monthly income (ETB)

 < 1000

117 (48.5)

1000–2000

72 (29.9)

 > 2000

52 (21.6)

Family size

2–4

172 (71.4)

5–8

69 (28.6)

HIV status of care giver

Positive

204 (84.6)

Negative

37 (15.4)

HIV Viral load (at the time of data collection)

Not detected

112 (46.5)

 ≤ 1000

77 (32)

 > 1000

52 (21.6)

WHO HIV stage (at the time of data collection)

I

232 (96.4)

II

9 (3.7)

HAART classification

ABC-3TC-LPV/r

19 (7.9)

ABC-3TC-DTG

46 (19.1)

ABC-3TC-NVP

6(2.5)

AZT-3TC-EFV

26(10.8)

AZT-3TC-LPV/r

7(2.9)

AZT-3TC-NVP

39(16.2)

TDF-3TC-DTG

50(20.7)

TDF-3TC-EFV

26(10.8)

TDF-3TC-LPV/r

14(5.8)

 

Others

8(3.3)

WAZ group

Under weight

15 (6.2)

Normal

226 (93.8)

HAZ group

Stunted

106 (44)

Normal

135 (56)

BAZ group

Under weight

41 (17)

Normal

200 (83)

Hepatitis seropositivity

HBsAg positive

23 (9.5)

Anti-HCV Abs positive

7 (2.9)

  1. Others: ABC-3TC-EFV = 3, AZT-3TC-DTG = 3, and TDF-3TC-NVP = 2, 3TC- lamivudine, ABC: abacavir, AZT: zidovudine, DTG: dolutegravir, EFV: efavirenz, LPV/r: lopinavir/ritonavir, NVP: nevirapine, TDF: tenofovir disoproxil fumarate, ETB: Ethiopian birr, WAZ: Weight-for-Age, HAZ: Height-for-Age, BAZ: Body Mass Index for Age